Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by MrMugsyon Jul 22, 2021 4:34pm
177 Views
Post# 33591473

Sorry Porky ... wrong again !

Sorry Porky ... wrong again !Sorry Porky ... wrong again

------------------
Porky: 
"Who has/is purchasing Meir's shares? Has he sold all or some? That pie will be carved by hundreds. Why not get accurate data instead of claiming someone from the AGM from 2017 said. The shareholder base has long since been flipped and continues to be flipped."
------------------

First, we are not talking about 2017.  Not sure why you make-up numbers.

May 21, 2021 AGM voting tells a different story than what you're assuming Porky.
The base has not changed much and Goodman's vote of confidence is the same.

I would also expect that some top shareholders are continuing to buy as they are still fully committed to the plan and thier ownership is likely to grow while there's a stock sale going on here.



DIRECTOR NOMINEE OUTCOME VOTES FOR % FOR VOTES WITHELD % WITHELD
James C. Gale Elected 82,398,355 99.27% 605,269 0.73%
Jonathan Ross Goodman Elected 82,969,724 99.96% 33,900 0.04%
Samira Sakhia Elected 82,436,218 99.32% 567,406 0.68%
Robert N. Lande Elected 77,942,162 93.90% 5,061,462 6.10%
Michael J. Tremblay Elected 72,120,789 86.89% 10,882,835 13.11%
Nicols Sujoy Elected 82,961,264 99.95% 42,360 0.05%
Janice Murray Elected 79,161,326 95.37% 3,842,298 4.63%


So ... if Goodman still has a 99.96% approval rating - and - he's going to become the Chairman of the Board ... don't you think a growing negative crowd would have impacted the voting ?

Seriously !!!

No idea when Meir's shares will be carved out or exactly what the details of that will be.  The voting doesn't seem to indicate much/if any shares have been sold yet.  We just don't know the details of the share sale but didn't he have up to 5 years to do so?  There is likely a good reason he was given 5 years to sell and I'd guess the selling will be backend-loaded.

Not sure what you mean that we're on the same side - and - not sure what you're aguing.  You seem to think the comments I make are equivalent to waving large signs that say "BUY KNIGHT SHARES NOW !   HURRY ! HURRY !

I don't think it sounds like that at all.  

Peace Brother !
<< Previous
Bullboard Posts
Next >>